Search

everythinglearnresearchcommunity

for

Search:↓

Patients with severe alopecia areata felt better and less anxious or depressed when treated with baricitinib compared to placebo.

Ritlecitinib is safe and may effectively treat alopecia areata.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

YH0618 helped reduce skin and nail problems and fatigue in chemotherapy patients.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

Neurosteroids help regulate oxytocin levels, especially during stress and pregnancy, to protect against premature labor.

Low dose cyclical nutrition therapy can consistently and safely improve hair growth and density without needing anti-androgens.

Topical calcitriol is safe for preventing hair loss during chemotherapy.

Human foreskin fibroblast–conditioned medium improved hair growth in androgenetic alopecia patients.

Both low-level light therapy and 5% minoxidil are effective and safe for treating male hair loss, with no significant difference in results.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Bariatric surgery improves ovulation rates in women with PCOS and obesity better than medical therapy.

Ritlecitinib and brepocitinib effectively regrow hair in alopecia areata patients.

Scalp cooling effectively reduces hair loss from chemotherapy.

PRP combined with minoxidil is the most effective and safe treatment for male pattern baldness.

The drug combination was safe and showed promise in treating advanced tumors.

Dutasteride reduces DHT more than finasteride, but both drugs improve BPH symptoms similarly.

Cyanidin 3-O-arabinoside may help treat a common form of hair loss by protecting cells against aging and improving cell function.

ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.

Keratinocyte Growth Factor-Hair Serum may help prevent hair loss during chemotherapy, but more research is needed.

CG2001 is safe and well-tolerated for treating hair loss, with fewer side effects than oral finasteride.

Clinical trials should use innovative designs and biomarkers to improve precision therapy and patient outcomes.

Triamcinolone is more effective than methotrexate for treating localized alopecia areata.

The trial is testing if a helmet that uses light can prevent hair loss during chemotherapy.

New cells join the hair's dermal papilla during the growth phase, possibly affecting hair thickness.

Low-level light therapy significantly increased hair density and thickness in people with hair loss, but they didn't notice a difference.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

Combining red laser therapy with minoxidil improves hair growth more effectively than minoxidil alone in women with hair loss.

Phage-containing hydrogels effectively heal wounds infected with Enterococcus faecalis.

JAK inhibitors effectively regrow hair in children with alopecia areata and are safe to use.